Naomi Iwata Selected Research

Naomi Iwata Research Topics

Disease

16	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 03/2021 - 01/2004
5	Infections 12/2021 - 09/2013
4	Fever (Fevers) 01/2020 - 01/2004
4	Arthritis (Polyarthritis) 04/2019 - 01/2004
3	Dermatomyositis (Dermatopolymyositis) 09/2019 - 12/2015
2	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 07/2022 - 01/2020
2	Macrophage Activation Syndrome 01/2020 - 01/2004
2	Autoimmune Diseases (Autoimmune Disease) 11/2019 - 10/2015
2	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2019 - 12/2015
2	Melanoma (Melanoma, Malignant) 12/2015 - 05/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2022
1	Rheumatic Diseases (Rheumatism) 07/2021
1	Body Weight (Weight, Body) 07/2021
1	Pyoderma Gangrenosum 01/2021
1	Ulcer 01/2021
1	Crohn Disease (Crohn's Disease) 10/2020
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 10/2020
1	Myositis (Idiopathic Inflammatory Myopathies) 09/2019
1	Uveitis 04/2019
1	Hypersensitivity (Allergy) 03/2019
1	Takayasu Arteritis (Arteritis, Takayasu's) 07/2018
1	Polyarteritis Nodosa (Periarteritis Nodosa) 07/2018
1	Iridocyclitis 01/2017
1	Localized Scleroderma (Morphea) 01/2017
1	Hepatitis B 05/2015
1	Tuberculosis (Tuberculoses) 05/2015
1	Virus Diseases (Viral Diseases) 09/2013
1	Leukopenia 09/2013
1	Human Influenza (Influenza) 09/2013
1	Inflammation (Inflammations) 09/2013
1	Rheumatoid Arthritis 08/2012
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 08/2012
1	Acute Retinal Necrosis Syndrome 09/2009
1	Necrosis 09/2009
1	Fibrosis (Cirrhosis) 06/2009
1	Exanthema (Rash) 01/2004
1	Disease Progression 01/2004
1	Serositis 01/2004
1	Systemic Scleroderma (Systemic Sclerosis) 10/2003

Drug/Important Bio-Agent (IBA)

9	tocilizumab (atlizumab)FDA Link 01/2020 - 03/2005
4	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021 - 06/2009
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 01/2004
3	SteroidsIBA 07/2022 - 01/2004
3	Adalimumab (Humira)FDA Link 03/2021 - 12/2012
3	Interleukin-6 (Interleukin 6)IBA 09/2013 - 01/2004
2	VaccinesIBA 07/2021 - 01/2020
2	Interleukin-18 (Interleukin 18)IBA 01/2021 - 05/2015
2	Infliximab (Remicade)FDA Link 01/2020 - 04/2019
2	AutoantibodiesIBA 09/2019 - 01/2017
2	C-Reactive ProteinIBA 04/2019 - 09/2013
2	Methotrexate (Mexate)FDA LinkGeneric 04/2019 - 08/2012
2	AntibodiesIBA 04/2019 - 05/2015
2	Biological ProductsIBA 04/2019 - 07/2018
2	Monoclonal AntibodiesIBA 04/2014 - 02/2012
1	Prednisolone (Predate)FDA LinkGeneric 07/2021
1	canakinumab FDA Link 01/2021
1	Ferritins (Ferritin)IBA 01/2020
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2020
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 11/2019
1	Abatacept (Orencia)FDA Link 04/2019
1	Ophthalmic Solutions (Eye Drops)IBA 04/2019
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 07/2018
1	B-Cell Activating FactorIBA 12/2015
1	LigandsIBA 12/2015
1	MicroRNAs (MicroRNA)IBA 10/2015
1	Biomarkers (Surrogate Marker)IBA 10/2015
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 04/2014
1	Indicators and Reagents (Reagents)IBA 09/2013
1	Retinaldehyde (Retinal)IBA 09/2009
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 03/2005
1	CytokinesIBA 01/2004
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2003

Therapy/Procedure

4	Therapeutics 12/2021 - 10/2003
1	Heart-Assist Devices 12/2021
1	Artificial Respiration (Mechanical Ventilation) 12/2021
1	Enteral Nutrition (Feeding, Tube) 10/2020
1	Operative Surgical Procedures 07/2018